Estradiol and lipid levels in men with acute myocardial infarction


  • R. R. Aparna Department of Biochemistry, Narayana Medical College, Nellore, Andhra Pradesh, India
  • D. Raja Rajeswari Department of Biochemistry, Narayana Medical College, Nellore, Andhra Pradesh, India
  • K. Ramalingam Department of Biochemistry, Narayana Medical College, Nellore, Andhra Pradesh, India
  • T. Sharmila Krishna Department of Biochemistry, Narayana Medical College, Nellore, Andhra Pradesh, India
  • R. Viswa Kumar Department of Biochemistry, Narayana Medical College, Nellore, Andhra Pradesh, India



Cardiovascular disease, Estradiol, High density lipoprotein, Myocardial infarction


Background: The incidence of myocardial infarction (MI) is more common in men when compared with women and women after menopause are at high risk of MI. This gender difference in CVD risk might be because of the difference in the circulating estrogen levels in men and women. Dyslipidemia is also one of the major causes of MI. The present study was aimed to estimate the levels of serum estradiol and serum lipids in newly diagnosed male MI cases and to find out any correlation between these two.

Methods: The study was conducted on 50 newly diagnosed MI admitted in Cardiology department Narayana general hospital and Medical College, Nellore. Only males were included in the study. Fifty age and sex-matched healthy individuals were selected as controls. Lipid levels are estimated by endpoint colorimetric assay (HUMANSTAR kit) and estradiol was estimated by Chemiluminance immune assay (CLIA).

Results: Significantly raised levels of estradiol (p-value <0.0001) and low HDL cholesterol (p-value =0.0085) levels were noticed among the cases compared to controls. No significant correlation was observed between estradiol and lipoproteins (HDL and LDL).

Conclusions: The results of the present study in acute MI compared to controls show hyper estrogenemia in Male MI cases, which may be the underlying cause for thrombosis in acute MI. Decreased levels of HDL cholesterol are observed in the MI cases which are known to increase the risk of Atherosclerosis. No significant correlation were noticed between Estradiol and HDL cholesterol in men with acute MI.


Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India current epidemiology and future directions. Circulation. 2016;133:1605-20.

Frangogiannis NG. Pathophysiology of myocardial infarction. The Wilf Family Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA. 2015;5(4):1841-75.

Muter A, Dack S, Jnrfe A. Sex and hypertension in myocardial infarction due to coronary artery diseases. Arch Intern Med. 1939;64:767-86.

Ostadal B, Prochazka J, Pelouch V, Urbanova D, Widimsky J. Comparison of cardiopulmonary responses of male and female rats to intermittent high altitude hypoxia. Physiol Bohemoslov. 1984;33:129-38.

Barta E, Strec V, Styk J, Okolicany J, Rajecova O. Protective effect of oestradiol on the heart of rats exposed to acute ischaemia. Physiol Bohemoslov. 1989;38:193-200.

Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. 1994 acute vascular effects of estrogen in postmenopausal women. Circulation. 2005;90:786-91.

Giri S, Thompson PD, Taxel P. Oral estrogen improves serum lipids, homocysteine, and fibrinolysis in elderly men. Atherosclerosis. 1998;137:359-66.

Ohshige A, Ito M, Koyama H, Maeda T, Yoshimura T, Okamura H. Effects of estrogen and progesterone on plasma platelet-activating factor acetyl hydrolase activity and low-density lipoprotein cholesterol concentration in men. Artery. 1996;22:115-24.

Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ: Atherosclerosis: Basic mechanisms, oxidation, inflammation and genetics. Circulation. 1995;91: 2448-96.

Bagatell CJ, Knopp RH, Rivier JE, Bremner WJ. Physiological levels of estradiol stimulate plasma high density lipoprotein 2 cholesterol levels in normal men. J Clin Endocrinol Metab. 1994;78:855-61.

Gerald B. Phillips ,Bruce H. Pinkernell , and Tian-Yi Jing Association of Hyperestrogenemia With Coronary Thrombosis in Men , Originally published 1 Nov 1996 Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1383-7.

Phillips GB, Pinkernell BH, Jing TY. Association of hyperestrogenemia with coronary thrombosis in men. Arterioscl Thromb Vascular Biol. 1996;16:1383-7.

Kaltua AA, Rosa G. Hall V, Cardiovascular beta adrenergic response. Berkeley, California, University of California Presa, 1970:1-281.

Greengrass PM, Tonge SR. The accumulation of noradrenaline and 5-hydroxytrptamine in three regions of mouse brain after tetrabenazine and iproniazid: effect of ethinyloeatradiol and progelttrone. Psychopharmacol. 1974;39:187-91.

Tripathi Y, Hegde M. Serum estradiol and testosterone levels following acute myocardial infarction in men. Indian J Physiol Pharmacol. 1998;42:291-4.

Graham I, Atar D, Borch JK, Boysen G, Burell G, Cifkova R. European guidelines on cardiovascular disease prevention in clinical practice executive summary. Atherosclerosis. 2007;194:1-45.

Khan H, Abdulla S. Lipid profile of patients with acute myocardial infarction and its correlation with systemic inflammation. Biomarkers Insight. 2013;9:81-7.

Tomaszewski M, Charchar FJ, Maric C, Kuzniewicz R, Gola M, Grzeszczak W, et al. Association between lipid profile and circulating concentrations of estrogens in young men. Atherosclerosis. 2009;203(1):257-62.




How to Cite

Aparna, R. R., Rajeswari, D. R., Ramalingam, K., Krishna, T. S., & Kumar, R. V. (2020). Estradiol and lipid levels in men with acute myocardial infarction. International Journal of Research in Medical Sciences, 8(3), 989–992.



Original Research Articles